Dataset grows to more than 312,000 whole genomes with longitudinal clinical data GSK is one of the first to lead a further expansion of 50,000 whole genomes paired with proteomic data  SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), and Nashville Biosciences, LLC (NashBio), today announced two advancements in scale and depth of the Alliance for Genomic Discovery (AGD […]
Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money. RADNOR, Pa. — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its Simcyp® Simulator enabled physiologically-based pharmacokinetic (PBPK) modeling predictions accepted by the U.S. FDA in lieu of clinical studies to support the new drug application […]
London, United Kingdom, Wetzlar, Germany / Beijing, China – Leica Microsystems, a Danaher company and a leading provider of microscopy and scientific solutions, announced that its President and CEO, Dr. Annette Rinck, accompanied German Federal Chancellor Friedrich Merz as part of the German economic delegation during the state visit to China on February 25 and […]
Increased adoption of clinical whole-genome sequencing is advancing diagnostics for rare diseases, which affect 15 million American children SAN DIEGOÂ — Illumina, Inc. (NASDAQ: ILMN) today announced that Illumina Laboratory Services, Illumina’s CLIA-certified laboratory, is providing clinical sequencing and interpretation services to the new Diagnostic Lab at Florida Institute for Pediatric Rare Diseases (IPRD) at Florida […]
~30,000 ft2Â center will help biopharma shorten development timelines, reduce risk, and scale with confidence Supports multiple modalities including mAbs, pDNA/mRNA, recombinant proteins, and viral vectors Cytiva, a Danaher company and a leader in the life sciences industry, has inaugurated an expanded facility for Fast Trak process development (PD) and validation services in Bengaluru, India. The […]
Vizgen will expand applications of MERSCOPE Ultra™ platform to include spatially-resolved molecular profiling of organoids; company has expansive pipeline and is progressing toward multiple breakthrough capabilities WALTHAM, Mass. — Vizgen, Inc., a leader in spatial multi-omics at single-cell resolution, today announced a series of innovations under development to help accelerate drug discovery, advance understanding of disease […]
CAMBRIDGE, England — Following a record Q4 in sales volume and the successful closing of $50 million in new funding, bit.bio is leveraging its economies of scale to substantially lower the price per vial of its ioCellsâ„¢ portfolio. This initiative is further strengthened by the launch of bit.bio’s second dedicated distribution hub, expanding on its […]
Team hosts launch event celebrating the move to a leading UK hub for science and innovation Macclesfield, UK — Phenomenex Inc., a global leader in the separation sciences, is pleased to announce that its UK team has relocated to a new office at The Glasshouse, Alderley Park; one of the United Kingdom’s foremost centers for scientific […]
ATLANTA, GA — Axion BioSystems today announced that the FDA’s Center for Drug Evaluation and Research (CDER) has accepted the company’s letter of intent (LOI) into the Innovative Science and Technology Approaches for New Drugs (ISTAND) Program for its Human iPSC-Cardiomyocyte MEA Assay for Prediction of Clinical Cardiovascular Repolarization Risk. The submission represents the first stem cell-derived, […]
Eppendorf, a leading life sciences company, is excited to announce a substantial new price point for its popular epMotion 5073 automated liquid handling system. This change reflects Eppendorf’s commitment to making liquid handling automation more attainable for all laboratories, supporting greater efficiency and consistency in everyday lab workflows without compromising on Eppendorf’s known superior quality […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
